Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
524.8 USD | +1.16% | +0.41% | +13.36% |
Apr. 18 | Nephron Research Raises McKesson's Price Target to $600 From $530 | MT |
Apr. 15 | Morgan Stanley Adjusts Price Target on McKesson to $548 From $522 | MT |
Evolution of the average Target Price on McKesson Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering McKesson Corporation
Nephron Research | |
Morgan Stanley | |
Argus | |
Deutsche Bank Securities | |
UBS | |
Leerink Partners | |
Mizuho Securities | |
Citigroup | |
Baird | |
Evercore ISI | |
Wells Fargo Securities | |
TD Cowen | |
JPMorgan Chase | |
Credit Suisse | |
BofA Securities | |
Barclays | |
Cowen | |
Cross Research | |
Goldman Sachs |
EPS Revisions
- Stock Market
- Equities
- MCK Stock
- Consensus McKesson Corporation